Globenewswire
Search documents
Lifeward Announces Reverse Share Split
Globenewswire· 2026-02-20 13:00
Reverse split initiated as Lifeward enters strategic partnership agreement and repositions as MedTech innovation companyHUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, today announced that effective with the open of the market on February 24, 2026, the Company will complete a 1-for-12 rever ...
SoundThinking Announces Fourth Quarter and Full-Year 2025 Financial Results Date and Conference Call; Participation in Upcoming Investor Conference
Globenewswire· 2026-02-20 13:00
FREMONT, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc. (Nasdaq: SSTI) (“SoundThinking” or the “Company”), a leading public safety technology company, today announced the date for the release of its fourth quarter and full-year 2025 financial results and its participation in an upcoming investor conference. Fourth Quarter and Full-Year 2025 Earnings Date SoundThinking will host a conference call on Tuesday, March 3, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its finan ...
SRx Health Solutions Announces Receipt of Warning Letter from NYSE American
Globenewswire· 2026-02-20 13:00
NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that on February 18, 2026, it received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”). The Letter relates to the issuance of approximately 7.5 million shares (the “Subj ...
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Globenewswire· 2026-02-20 13:00
REDWOOD CITY, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for lung disease, today announced that it will release financial results for the fourth quarter and full year of 2025 after the close of trading on Wednesday, March 4, 2026. Company management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast of the event will be available on the “ ...
SRx Health Solutions Announces Receipt of Warning Letter from NYSE American
Globenewswire· 2026-02-20 13:00
NORTH PALM BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that on February 18, 2026, it received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”). The Letter relates to the issuance of approximately 7.5 million shares (the “Subj ...
Beyond Air® Comments on Landmark Independent Review Article Highlighting the Antimicrobial Effects of High-Dose Inhaled Nitric Oxide and its Therapeutic Potential for Treating Respiratory Infections
Globenewswire· 2026-02-20 13:00
GARDEN CITY, N.Y., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today commented on the publication of an independent review article providing the most comprehensive overview to date of high‑dose inhaled nitric oxide (iNO) delivered at concentrations well above the FDA‑approved 20 ppm, and presenting mounti ...
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
Globenewswire· 2026-02-20 13:00
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today presented data on its novel approach to the use of BiTEs in solid tumors by utilizing its systemically delivered RedTail platform at the AACR Immuno-Oncology (AACR-IO) conference being held in Los Angeles, California. A link to the poster is available here and on the company’s website. RedTail is C ...
Nasus Pharma to Participate in Upcoming Investor Conferences
Globenewswire· 2026-02-20 13:00
TEL AVIV, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ("Nasus Pharma" or the "Company"), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products, today announced that Company management will participate in upcoming investor conferences in February and March. Oppenheimer 36th Annual Healthcare Life Sciences Conference Date and time: February 25, 2026, 1:20 p.m. ETLocation: Virtual (register here: https://event.summitcast.com/view/CTtthLh2Bi2D9 ...
National Healthcare Properties Reports Fourth Quarter and Full Year 2025 Results
Globenewswire· 2026-02-20 13:00
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHPAP / NHPBP) (the “Company”), a self-managed diversified healthcare real estate investment trust focusing on senior housing and outpatient medical facilities, today announced results for the fourth quarter and full year ended December 31, 2025. Michael Anderson, Chief Executive Officer and President, commented, “We are very pleased with the exceptional internal growth of our senior housing portfolio and the steady pe ...
Society Pass Incorporated (Nasdaq: SOPA) and NusaTrip Incorporated (Nasdaq: NUTR) Respond to Nasdaq/SEC Questions Regarding Status of Trading of NUTR’s Securities; NusaTrip’s Operations Remain Normal and Unaffected by Trading Suspension
Globenewswire· 2026-02-20 13:00
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Society Pass Incorporated (Nasdaq: SOPA) (the “Company”), Southeast Asia’s (SEA) next generation e-commerce ecosystem, and its majority owned subsidiary, NusaTrip Incorporated (Nasdaq: NUTR) (“NusaTrip”), the leading SEA and Asia-Pacific-based (APAC) integrated travel technology platform, announces that NusaTrip filed a Form 8-K with the Securities and Exchange Commission (SEC) on February 3, 2026 regarding the status of trading in NusaTrip’s securities on The Na ...